Showing results (1371-1380 of 1,437) with videos related to
Sort By:
Pageof 144
Plos One|November 20, 2009
Profiling critical cancer gene mutations in clinical tumor samplesLaura E MacConaill, Catarina D Campbell, Sarah M Kehoe, et al.Physical Review Letters|February 9, 2005
Evidence for the decay sigma+ --> pmu+ mu-H K Park, R A Burnstein, A Chakravorty, et al.Cancer Cell|June 10, 2008
The role of SPINK1 in ETS rearrangement-negative prostate cancersScott A Tomlins, Daniel R Rhodes, Jianjun Yu, et al.Cancer Discovery|October 3, 2018
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell LymphomagenesisPilar M Dominguez, Hussein Ghamlouch, Wojciech Rosikiewicz, et al.NPJ Precision Oncology|May 27, 2021
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemiaMayumi Sugita, David C Wilkes, Rohan Bareja, et al.The Journal of Pathology|May 4, 2012
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancerAnna V Lapuk, Chunxiao Wu, Alexander W Wyatt, et al.Physical Review Letters|March 23, 2002
Observation of the decay K- --> pi(-)mu(+)mu(-) and measurements of the branching ratios for K+/- --> pi(+/-)mu(+)mu(-)H K Park, R A Burnstein, A Chakravorty, et al.Plos One|April 23, 2021
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US VeteransCatherine G Derington, Jordana B Cohen, April F Mohanty, et al.Physical Review Letters|February 9, 2005
Search for CP violation in charged-Xi and Lambda hyperon decaysT Holmstrom, N Leros, R A Burnstein, et al.Physical Review Letters|March 24, 2005
Search for DeltaS = 2 nonleptonic hyperon decaysC G White, R A Burnstein, A Chakravorty, et al.Pageof 144